ArticleVirology journal2026
Divergent immunometabolic landscapes of chicken and swan goose identify SERPINF2 as a novel restriction factor for influenza A virus.
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
As the natural hosts of avian influenza virus (AIV), wild birds generally exhibit a more tolerant immune response to AIV infection compared to domestic poultry. However, the underlying mechanisms remain incompletely understood, partly due to limited access to wildlife biological samples imposed by animal protection principles. To investigate these differential immune responses, we established a peripheral blood mononuclear cells (PBMCs) infection platform. PBMCs from domestic chickens and swan geese were infected with H9N2 AIV, and label-free quantitative comparative proteomics was performed to identify differentially expressed proteins (DEPs) between the two species, aiming to uncover potential host antiviral factors. Proteomic analysis revealed that chicken PBMCs showed marked activation of antiviral defense and inflammatory pathways, accompanied by upregulation of oxidative stress-related pathways. In contrast, swan goose PBMCs predominantly activated pathways associated with cellular integrity maintenance, metabolic homeostasis, and RNA surveillance. Subsequently, 12 DEP candidates with high expression fold-changes in swan goose PBMCs were selected and expressed in DF-1 cells to evaluate their antiviral activities. Among these, only SERPINF2, a member of the serine protease inhibitor family, significantly inhibited H9N2 AIV replication in DF-1 cells. Mechanistically, SERPINF2 suppressed viral replication by specifically inhibiting the cleavage of the viral hemagglutinin (HA) protein, thereby reducing the production of infectious progeny virions. This study reveals distinct immune response patterns to H9N2 AIV infection in chickens and swan geese, and identifies SERPINF2 as a novel restriction factor against H9N2 AIV, providing new insights into the antiviral mechanisms in natural AIV hosts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.